Gastroenterology · Los Angeles, CA
NPI
1679650675
Since 2006
Specialty
Gastroenterology
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
266 S Harvard Blvd Ste 250
Los Angeles, CA, 90004
Phone (213) 387-9000
Groups this clinician bills Medicare through
Medicare paid, 2024
$135K
1,280 services
Medicare patients, 2024
593
Average age 76
Drug cost, 2024
$56K
2,644 prescriptions
Company payments, 2023
$73.18
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Myung Choi was code 43235 (upper gi endoscopy), 362 times for 357 patients. In total Myung Choi billed 1,280 services in 32 codes, and Medicare paid $135K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-05-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 43235 Upper GI Endoscopy | Facility | 362 | 357 | $85.17 | $31K |
| 99204 Office E&M - New | Office | 265 | 265 | $129.55 | $34K |
| 99214 Office E&M - Established | Office | 175 | 154 | $87.05 | $15K |
| 43239 Upper GI Endoscopy | Facility | 101 | 98 | $88.53 | $8,941 |
| 45378 Lower GI Endoscopy - Other | Facility | 91 | 87 | $142.74 | $13K |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 62 | 62 | $178.54 | $11K |
| 45384 Colonoscopy - Lesion Removal | Facility | 50 | 50 | $105.59 | $5,279 |
| 45385 Colonoscopy - Lesion Removal | Facility | 36 | 36 | $175.83 | $6,330 |
| 36415 Venipuncture Blood Collection | Office | 17 | 15 | $8.65 | $147 |
| 99203 Office E&M - New | Office | 14 | 14 | $84.28 | $1,180 |
| 45331 Lower GI Endoscopy - Other | Facility | 14 | 14 | $50.71 | $710 |
| 99213 Office E&M - Established | Office | 13 | 11 | $73.77 | $959 |
| 45380 Lower GI Endoscopy - Other | Facility | 13 | 12 | $122.24 | $1,589 |
By year: 2022 $222K for 2,034 services; 2023 $171K for 1,523 services; 2024 $135K for 1,280 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 17 | 15 | $8.65 | $147 |
Medicare prescription drug claims, 2024
In 2024, the drug Myung Choi prescribed most often to Medicare patients was Gavilyte-G (Peg3350/Sod Sulf,bicarb,cl/Kcl), with 1,091 prescriptions and refills. In total Myung Choi wrote 2,644 Medicare prescriptions that cost $56K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 1,091 | 1,102 | 1,049 | $17K |
| Omeprazole Generic | 386 | 472 | 203 | $1,663 |
| Pantoprazole Sodium Generic | 242 | 312 | 121 | $1,140 |
| Peg-3350 And Electrolytes Peg3350/Sod Sulf,bicarb,cl/Kcl | 207 | 207 | 203 | $3,253 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 168 | 168 | 165 | $11K |
| Metronidazole Generic | 160 | 160 | 149 | $704 |
| Gavilyte-C Peg3350/Sod Sulf,bicarb,cl/Kcl | 103 | 105 | 100 | $1,991 |
| Amoxicillin Generic | 91 | 91 | 90 | $461 |
| Famotidine Generic | 27 | 35 | 13 | $188 |
| Peg 3350-Electrolyte Sodium Chloride/Nahco3/Kcl/Peg | 17 | 17 | 17 | $408 |
| Sulfasalazine Generic | 16 | 22 | Under 11 | $342 |
| Spironolactone Generic | 16 | 24 | Under 11 | $237 |
| Mesalamine Generic | 14 | 24 | Under 11 | $8,406 |
| Suprep Sodium, Potassium,mag Sulfates | 12 | 12 | 12 | $1,352 |
Brand drugs: 217 claims; generic drugs: 2,427 claims.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Myung Choi $73.18 ($73.18 in general payments such as food, travel and fees) from 1 company. The largest payer was Boston Scientific Corporation with $73.18.
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation BSX | 3 | $73.18 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.